Who Paid My Doc
Hong Li
Clinical Genetics (M.D.) Decatur, GA Medical Doctor
NPI 1811160609 CMS profile 585635
2165 N Decatur Rd, Decatur, GA 30033
General payments
$97,925
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$247,741
Through program year 2025, Hong Li of Decatur, GA is reported in the CMS Open Payments database as having received $97,925 across 30 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $247,741 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 93rd percentile of Clinical Genetics (M.D.) profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $91,357 | 21 | |
| 2023 | General | $2,750 | 4 | |
| 2022 | General | $125 | 1 | |
| 2021 | General | $3,200 | 1 | |
| 2020 | General | $125 | 1 | |
| 2019 | General | $368 | 2 |
Beside peers
- Hong Li
- Clinical Genetics (M.D.) median
- Middle half of Clinical Genetics (M.D.)
- National median
In program year 2025, general payments to Hong Li were reported at $91,357. Among 315 Clinical Genetics (M.D.) profiles paid that year, the median was $255 and the middle half received between $85 and $3,583.
Show as a table
| Year | Hong Li | Clinical Genetics (M.D.) median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $368 | $130 | $24–$2,691 | $163 |
| 2020 | $125 | $126 | $30–$3,700 | $114 |
| 2021 | $3,200 | $185 | $30–$3,777 | $132 |
| 2022 | $125 | $136 | $44–$2,749 | $149 |
| 2023 | $2,750 | $196 | $55–$5,220 | $160 |
| 2024 | $0 | $165 | $46–$3,171 | $164 |
| 2025 | $91,357 | $255 | $85–$3,583 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
29
Drug cost
$665,281
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Fabrazyme Agalsidase Beta | Brand | 13 | $465,476 | |
| Palynziq Pegvaliase-Pqpz | Brand | 16 | $199,805 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,361 Part D prescribers listed as Pediatric Medicine; they describe a distribution and say nothing about conduct.
Records
30 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Genetics (M.D.) in Georgia
William Wilcox
Clinical Genetics (M.D.) · Decatur, GA
Jaime Vengoechea Barrios
Clinical Genetics (M.D.) · Atlanta, GA
Michael Gambello
Clinical Genetics (M.D.) · Decatur, GA
Suma Shankar
Clinical Genetics (M.D.) · Decatur, GA
Rossana Sanchez Russo
Clinical Genetics (M.D.) · Atlanta, GA
Faizal Asumda
Clinical Genetics (M.D.) · Augusta, GA
Related records
Clinical Genetics (M.D.) in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Genetics (M.D.)
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.